Skip to main content

Table 1 The demographic characteristics of the study population

From: Evaluation of the relationship between MARCO and CD36 single-nucleotide polymorphisms and susceptibility to pulmonary tuberculosis in a Chinese Han population

 

Patients

Controls

P

Characteristics

Sex

  

0.133

 Female

59(29.2%)

78(36.1)

 

 Male

143(70.8%)

138(63.9)

 

Age yrs

47.3 ± 19.4

48.5 ± 13.4

0.44

Smoking

 Smoking

55(27.2%)

ND

 

 Nonsmoking

127(62.9%)

ND

 

 Ever Smoking

20(9.9%)

ND

 

Laboratory findings

TP (65-85 g/L)

 < 65

49(24.3%)

21(9.7%)

 

 65–85

148(73.2%)

195(90.3%)

 

 ND

5(2.5%)

0

 

Alb (40-55 g/L)

 < 40

85(42.1%)

16(7.4%)

 

 40–55

112(55.4%)

200(92.6%)

 

 ND

5(2.5%)

0

 

TG (0.00–1.70 mm/L)

 0.00–1.70

148(73.3%)

156(72.2%)

 

 > 1.70

21(10.4%)

60(27.8%)

 

 ND

33(16.3%)

0

 

TC (0.00–5.72 mm/L)

 0.00–5.72

149(73.8%)

187(86.6%)

 

 > 5.72

20(9.9%)

29(13.4%)

 

 ND

33(16.3%)

0

 

LDL-C (0.00–3.64 mm/L)

 0.00–3.64

146(72.3%)

171(79.2%)

 

 > 3.64

23(11.4%)

45(20.8%)

 

 ND

33(16.3%)

0

 

HDL-C (0.91–1.92 mm/L)

 < 0.91

78(38.6%)

16(7.4%)

 

 0.91–1.92

91(45.1%)

189(87.5%)

 

 > 1.92

0

11(5.1%)

 

 ND

33(16.3%)

0

 

ESR

 Increase

148(73.3%)

ND

 

 Normal

40(19.8%)

ND

 

 ND

14(6.9%)

ND

 

Clinical phenotype

 Pulmonary tuberculosis

202

  

 Culture positive

107(53.0%)

ND

 

 Smear positive

48(23.8%)

ND

 

 Culture/smear positive

47(23.2%)

ND

 

Radiographic findings

 Infiltrative PTB

142(70.3%)

ND

 

 Cavity PTB

60(29.7%)

ND

 

System involvment

 TB pleurisy

22(10.9%)

ND

 

 Disseminated TB

3(1.5%)

ND

 

 Extra pulmonary involvement

10(4.9%)

ND

 

 None

167(82.7%)

ND

 

Treatment times

 Initial treatment

98(48.5%)

ND

 

 Retreatment

104(51.5%)

ND

 
  1. ND, Not determined